Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anyupeibo Capsule Dose-finding Study in Depression
CTR20150184Phase 2Completed
- Sponsor
- Suzhou YiHua Biomedical Technology
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YH-200 in major depressive disorder (MDD), sponsored by Suzhou YiHua Biomedical Technology. Started Apr 2015; status: completed.
02
Drugs
YH-200
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20150184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150184.